PEPCELLERATE
LIVE

Serial Number

79455109

Owner

Corden Pharma International GmbH

Filing Date

May 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PEPCELLERATE Trademark

Serial Number: 79455109

PEPCELLERATE is a trademark filed by Corden Pharma International GmbH on May 6, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Corden Pharma International GmbH (6 trademarks)

Otto-Hahn-Strasse

Entity Type: 99

Trademark Details

Filing Date

May 6, 2026

Registration Date

Not Registered

Goods & Services

Chemicals for use in industry and science; biological preparations for use in industry and science; peptides for industrial purposes; peptide substrates for scientific purposes; amino compounds; amino acids for industrial purposes; preservatives for pharmaceuticals; chemicals for use in manufacturing pharmaceuticals; active chemical ingredients; diagnostics preparations, other than for medical or veterinary use.

Pharmaceuticals; pharmaceutical preparations; medical preparations; veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for veterinary use; dietetic substances adapted for medical use; dietetic substances for babies; dietary supplements; synthetic peptides for pharmaceutical purposes; amino acids for veterinary purposes; amino acids for medical purposes; amino acid preparations for medical purposes; clinical medical reagents; clinical diagnostic reagents.

Scientific and technological services; scientific and technological design; scientific research; technological research; industrial analysis and research services; chemical analysis; chemical research; chemical engineering; chemical laboratories; pharmaceutical products development; research of pharmaceuticals; testing of pharmaceuticals; development of pharmaceutical preparations and medicines; research relating to medicine; development of gene-based medicines; pharmaceutical product evaluation; clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical research.

Custom manufacture of pharmaceuticals; custom biomanufacturing of pharmaceuticals; processing of chemicals; provision of information relating to chemical processing; treatment of chemical and medical waste; custom manufacture of medical devices for others; information in relation to the above services.

Filing History

SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 30, 2026 REPR